Summary. My 'Sell' rating on CVS Health has performed well so far, as the stock is down more than 20% on a total shareholder return basis. There's no end in sight for margin contraction in the ...

CVS Health explores splitting its retail and insurance units to address investor concerns and financial challenges. The potential breakup could unwind the $70 billion Aetna acquisition made in 2017.

The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it ...

CVS Health has identified a “multi-year opportunity” to deliver $2 billion in savings, said President and CEO Karen Lynch during a call discussing the retailer’s Q2 financial results. The cuts will ...

CVS Health Corp.’s stock tumbled 10.5% early Friday, after the healthcare company announced leadership changes and lowered guidance for the fourth time this year, weighed down by challenges in ...

CVS Health is trading at an EBITDA multiple of 7x, which is significantly lower than key competitors like UnitedHealth Inc (NYSE:UNH) and Cigna Inc (NYSE:CI), ...